August 8th, 2016: Understanding and Remembrance Day for Severe Myalgic Encephalomyelitis
Jody Smith joins with other ME voices in honor of Understanding and Remembrance Day for Severe Myalgic Encephalomyelitis.
Discuss the article on the Forums.

Curza Aims At Treatment For Lyme Disease With New Antibiotic

Discussion in 'Lyme Disease and Co-Infections' started by shannah, Aug 29, 2015.

  1. shannah

    shannah Senior Member

    From Rick Laferriere

    Utah drug research company, Curza, takes aim at Lyme disease By Chris Miller, KUTV-TV, Salt Lake City, Utah

    August 25, 2015

    Curza, a Provo-based pharmaceutical research company, is on the cusp of a medical breakthrough that could treat victims of chronic Lyme disease.

    The company is entering phase two of clinical research on their newly designed antibiotic called CZ-99. They'll soon be testing the drug on infected mice at the University of California, Davis.

    An initial clinical trial at the University of New Haven in Connecticut, found CZ-99 to be 60 percent more effective in treating Lyme disease than the traditional antibiotics used to treat the illness.

    Curza CEO Ryan Davies says they have a patent on a technology used to penetrate bacteria's protective outer layer, or biofilm, making its new antibiotic more effective than outdated medications.
    adreno likes this.

See more popular forum discussions.

Share This Page